Peripapillary Retinal Nerve Fiber Layer Thicknesses Did Not Change in Long-term Hydroxychloroquine Users.
- Author:
Eun Jung LEE
1
;
Sang Jin KIM
;
Jong Chul HAN
;
Doo Ri EO
;
Min Gyu LEE
;
Don Il HAM
;
Se Woong KANG
;
Changwon KEE
;
Jaejoon LEE
;
Hoon Suk CHA
;
Eun Mi KOH
Author Information
- Publication Type:Original Article
- Keywords: Hydroxychloroquine; Peripapillary retinal nerve fiber layer; Spectral-domain optical coherence tomography
- MeSH: Humans; Hydroxychloroquine*; Medical Records; Nerve Fibers*; Photography; Retinaldehyde*; Retrospective Studies; Tomography, Optical Coherence; Visual Field Tests
- From:Korean Journal of Ophthalmology 2018;32(6):459-469
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: To evaluate changes in the peripapillary retinal nerve fiber layer (RNFL) thicknesses using spectral-domain optical coherence tomography (SD-OCT) in hydroxychloroquine (HCQ) users. METHODS: The medical records of HCQ users were retrospectively reviewed. In these HCQ users, an automated perimetry, fundus autofluorescence photography, and SD-OCT with peripapillary RNFL thickness measurements were performed. The peripapillary RNFL thicknesses were compared between the HCQ users and the control groups. The relationships between the RNFL thicknesses and the duration or cumulative dosage of HCQ use were analyzed. RESULTS: This study included 77 HCQ users and 20 normal controls. The mean duration of HCQ usage was 63.6 ± 38.4 months, and the cumulative dose of HCQ was 528.1 ± 3.44 g. Six patients developed HCQ retinopathy. Global and six sectoral RNFL thicknesses of the HCQ users did not significantly decrease compared to those of the normal controls. No significant correlation was found between the RNFL thickness and the duration of use or cumulative dose. The eyes of those with HCQ retinopathy had temporal peripapillary RNFL thicknesses significantly greater than that of normal controls. CONCLUSIONS: The peripapillary RNFL thicknesses did not change in the HCQ users and did not correlate with the duration of HCQ use or cumulative doses of HCQ. RNFL thickness is not a useful biomarker for the early detection of HCQ retinal toxicity.
